Roche Drops Pursuit Of Denied India Patents For Breast Cancer Drug
This article was originally published in PharmAsia News
Executive Summary
Roche said it would not pursue restoration of its India patents for Herceptin (trastuzumab) for treating breast cancer, but would continue to fight to protect local patents on its other drugs.